The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
2SEVENTY BIO INC | COMMON STOCK | 901384107 | BBG00YV1J631 | 38,137,514 | 3,738,972 | SH | SOLE | 3,738,972 | 0 | 0 | ||
ALLOGENE THERAPEUTICS INC | COM | 019770106 | BBG00KHRRDY2 | 7,390,146 | 1,495,981 | SH | SOLE | 1,495,981 | 0 | 0 | ||
AMARIN CORP PLC | SPONS ADR NEW | 023111206 | BBG001SD42R0 | 18,000,000 | 12,000,000 | SH | SOLE | 12,000,000 | 0 | 0 | ||
ARCELLX INC | COMMON STOCK | 03940C100 | BBG00QHJM4W4 | 965,462 | 31,336 | SH | SOLE | 31,336 | 0 | 0 | ||
ARGENX SE | SPONSORED ADR | 04016X101 | BBG00GHB88Y8 | 1,676,610 | 4,500 | SH | Put | SOLE | 4,500 | 0 | 0 | |
BIOCRYST PHARMACEUTICALS INC | COM | 09058V103 | BBG001S7K151 | 8,340,000 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | ||
BURNING ROCK BIOTECH LTD | SPONSORED ADS | 12233L107 | BBG00V1JWFQ1 | 22,537,956 | 8,020,625 | SH | SOLE | 8,020,625 | 0 | 0 | ||
CATALYST BIOSCIENCES INC | COM NEW | 14888D208 | BBG001SDL5X7 | 18,606 | 89,886 | SH | SOLE | 89,886 | 0 | 0 | ||
CELLDEX THERAPEUTICS INC NEW | COM NEW | 15117B202 | BBG001S7QN20 | 50,712,047 | 1,409,451 | SH | SOLE | 1,409,451 | 0 | 0 | ||
CENTESSA PHARMACEUTICALS PLC | SPONSORED ADS | 152309100 | BBG01081FC68 | 2,806,946 | 729,077 | SH | SOLE | 729,077 | 0 | 0 | ||
COGENT BIOSCIENCES INC | COM | 19240Q201 | BBG007DHY102 | 4,315,719 | 399,974 | SH | SOLE | 399,974 | 0 | 0 | ||
CONNECT BIOPHARMA HLDGS LTD | ADS | 207523101 | BBG00ZGYNJZ5 | 739,575 | 739,649 | SH | SOLE | 739,649 | 0 | 0 | ||
GOSSAMER BIO INC | COM | 38341P102 | BBG00MVWLMC1 | 1,893,611 | 1,502,866 | SH | SOLE | 1,502,866 | 0 | 0 | ||
GSK PLC | SPONSORED ADR | 37733W204 | BBG001SD6SM6 | 17,730,546 | 498,329 | SH | SOLE | 498,329 | 0 | 0 | ||
HORIZON THERAPEUTICS PUB L | SHS | G46188101 | BBG001T9M4T2 | 119,466,827 | 1,094,620 | SH | SOLE | 1,094,620 | 0 | 0 | ||
IOVANCE BIOTHERAPEUTICS INC | COM | 462260100 | BBG001T2PM32 | 10,998,000 | 1,800,000 | SH | SOLE | 1,800,000 | 0 | 0 | ||
LIQUIDIA CORPORATION | COM NEW | 53635D202 | BBG001V0GFD7 | 11,347,906 | 1,642,244 | SH | SOLE | 1,642,244 | 0 | 0 | ||
MERUS N V | COM | N5749R100 | BBG00B8LXMT4 | 394,809 | 21,457 | SH | SOLE | 21,457 | 0 | 0 | ||
MIRATI THERAPEUTICS INC | COM | 60468T105 | BBG001SF6HK7 | 18,584,535 | 499,853 | SH | SOLE | 499,853 | 0 | 0 | ||
NATERA INC | COM | 632307104 | BBG001V0FSF8 | 162,020,518 | 2,918,237 | SH | SOLE | 2,918,237 | 0 | 0 | ||
NEOLEUKIN THERAPEUTICS INC | COM | 64049K104 | BBG005Y0QF99 | 83,976 | 119,966 | SH | SOLE | 119,966 | 0 | 0 | ||
OLEMA PHARMACEUTICALS INC | COM | 68062P106 | BBG00T5JMRV1 | 6,981,130 | 2,011,853 | SH | SOLE | 2,011,853 | 0 | 0 | ||
PROTAGONIST THERAPEUTICS INC | COM | 74366E102 | BBG002B63KP4 | 31,625,000 | 1,375,000 | SH | SOLE | 1,375,000 | 0 | 0 | ||
PUMA BIOTECHNOLOGY INC | COM | 74587V107 | BBG001TFZB81 | 1,461,786 | 473,070 | SH | SOLE | 473,070 | 0 | 0 | ||
RHYTHM PHARMACEUTICALS INC | COM | 76243J105 | BBG007DLZ629 | 1,652,020 | 92,602 | SH | SOLE | 92,602 | 0 | 0 | ||
SEAGEN INC | COM | 81181C104 | BBG001S9M4Q6 | 20,247,000 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
SERES THERAPEUTICS INC | COM | 81750R102 | BBG0099X6868 | 4,359,737 | 768,913 | SH | SOLE | 768,913 | 0 | 0 | ||
SUTRO BIOPHARMA INC | COM | 869367102 | BBG001T94MP6 | 4,166,482 | 901,836 | SH | SOLE | 901,836 | 0 | 0 | ||
SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | BBG001T92272 | 67,710,424 | 3,205,986 | SH | SOLE | 3,205,986 | 0 | 0 | ||
TRAVERE THERAPEUTICS INC | COM | 89422G107 | BBG001SL72C5 | 35,165,252 | 1,563,595 | SH | SOLE | 1,563,595 | 0 | 0 | ||
VAXCYTE INC | COM | 92243G108 | BBG009PHHPP4 | 45,605,064 | 1,216,784 | SH | SOLE | 1,216,784 | 0 | 0 | ||
VERA THERAPEUTICS INC | CL A | 92337R101 | BBG00Q72WYH2 | 26,170,041 | 3,372,428 | SH | SOLE | 3,372,428 | 0 | 0 | ||
VIRIDIAN THERAPEUTICS INC | COM | 92790C104 | BBG002H24301 | 13,829,260 | 543,603 | SH | SOLE | 543,603 | 0 | 0 | ||
WAVE LIFE SCIENCES LTD | SHS | Y95308105 | BBG00B642V63 | 16,488,103 | 3,807,876 | SH | SOLE | 3,807,876 | 0 | 0 | ||
XENON PHARMACEUTICALS INC | COM | 98420N105 | BBG002VBMLS5 | 1,027,030 | 28,696 | SH | SOLE | 28,696 | 0 | 0 |